Skip to Content
  • 4.3
    Impact Factor
  • 6.4
    CiteScore
  • 28 days
    Submission to First Decision
  • 6 days
    Acceptance to Publication

Proteomes

Proteomes is an international, peer-reviewed, open access journal on all aspects of proteomics published quarterly online by MDPI. Your place for critical, comprehensive proteomic studies contributing to systems-level understanding.

Get Alerted

Add your email address to receive forthcoming issues of this journal.

All Articles (564)

  • Review
  • Open Access

Late-life depression (LLD) is increasingly recognized as a complex multisystem disorder associated with accelerated biological aging, impaired physiological resilience, frailty, and an increased risk of cognitive decline and dementia. Although growing evidence supports the close relationship between depression, frailty, and neurodegeneration, the molecular mechanisms underlying this continuum remain incompletely understood. In particular, conventional clinical and imaging biomarkers capture established disease but provide limited insight into the systemic biological processes that precede neurodegeneration. Proteomics has emerged as a powerful systems biology approach capable of characterizing the dynamic molecular networks involved in aging, neuropsychiatric disorders, and neurodegenerative diseases. Recent advances in high-throughput mass spectrometry have identified alterations in proteins associated with chronic inflammation, complement activation, mitochondrial dysfunction, oxidative stress, lipid metabolism, synaptic integrity, neurotrophic signaling, and cellular senescence across LLD, frailty, cognitive impairment, and Alzheimer’s disease (AD). These convergent proteomic signatures suggest that these conditions may share common biological pathways consistent with progressive loss of physiological resilience rather than independent pathological entities. In this review, we examine the current evidence supporting shared proteomic mechanisms linking LLD, frailty, cognitive frailty (CF), and neurodegeneration. We discuss the potential integration of large-scale proteomic profiling with established AD biomarkers within the AT(N) framework to improve biological characterization, early risk stratification, and prediction of cognitive decline. Particular emphasis is placed on CF as a transitional and potentially modifiable phenotype in which systemic molecular dysregulation precedes overt neurodegeneration. By integrating evidence from geroscience, neuropsychiatry, and proteomics, we propose that proteomic profiling can redefine LLD and frailty as manifestations of a common biological vulnerability continuum. This systems-level perspective may facilitate the identification of individuals at high risk for dementia, support the development of multimodal biomarker panels, and advance precision neuropsychiatry through earlier diagnosis and personalized preventive interventions.

Proteomes

17 November 2026

Alzheimer’s disease (AD) clinical expression results from the dynamic interaction between neuropathological burden (x-axis) and biological vulnerability (y-axis). Disease biomarkers (Level 1) capture the presence and severity of AD pathology, whereas vulnerability biomarkers (Level 2) reflect systemic biological processes that determine the capacity to tolerate and respond to pathological insults. Individuals in the same level of pathology may experience different clinical trajectories depending on their resilience reserve. Cognitive frailty occupies an intermediate position, representing a transitional state in which increased vulnerability converges with emerging pathology.
  • Article
  • Open Access

Background: Sample loss during preparation is one of the issues in unveiling the complexity of the proteome. Here, we focused on minimizing peptide loss during their transfer and storage in autosampler vials prior to analysis. Methods: We used commercially available autosampler TPX vials and HeLa digest. Samples were acidified by formic acid, trifluoracetic acid or their combination and supplemented by polyethylene glycol (PEG, our commonly used additive), n-dodecyl-β-D-maltoside (DDM) or no additive at all. For each injection, 10 ng of peptides was administered at a volume of 10 µL; all samples were analyzed by LC-MS/MS. Results: The DDM-containing samples were able to minimize peptide losses. The addition of DDM outperformed the PEG in observed parameters such as the number of identified peptides throughout the LC gradient or the reduction in losses of high-mass peptides. DDM minimizes peptide losses in samples stored in the autosampler vials for at least seventy-two hours. Conclusions: Under the given experimental conditions, the addition of DDM is capable of replacing PEG and can be used to minimize peptide losses in autosampler vials. The use of DDM is therefore particularly advantageous for those types of samples where DDM cannot be used in the earlier stages of the sample preparation procedure.

Proteomes

13 November 2026

Schematic overview of experimental design. All samples were prepared in triplicate.
  • Article
  • Open Access

Background: Bovine serum albumin (BSA) is widely used as a reference material for protein quantification, assessment of mass spectrometry (MS) system performance, enzymatic digestion control, and numerous biochemical applications. Despite its presumed homogeneity, commercial BSA preparations may exhibit substantial molecular heterogeneity affecting analytical performance. Methods: Tryptic digests of four commercial BSA preparations (1 pmol) were characterized by nanoflow high-resolution liquid chromatography–tandem mass spectrometry (LC–MS/MS) and bioinformatic analyses alongside a standard of BSA tryptic peptides (50 fmol) routinely used for MS performance assessment. Results: Our investigation revealed multi-level molecular heterogeneity, encompassing: (i) copurified plasma proteins and, surprisingly, milk-derived proteins across all four analyzed commercial BSA preparations; (ii) non-specific proteolysis and diverse post-translational modifications, including adducts compatible with lysine lactylation or advanced glycation end products (AGEs), such as Nε-carboxyethyllysine; and (iii) genetic variants, including the cataloged Ala190Thr variant found in all four BSA preparations and the previously unreported Gly398Pro variant detected exclusively—yet consistently over a seven-year period—in the commercial BSA tryptic digest reference standard. These sources of heterogeneity influence protein composition, proteolytic behavior, physicochemical properties, and analytical parameters, indicating that commercial BSA preparations are not molecularly equivalent reference materials. Conclusions: Structural, genetic, chemical, and biological variability of BSA reflects the general underlying molecular complexity inherent to biologically derived preparations. Our findings challenge the conventional use of commercial BSA as a universal reference standard and highlight the need for routine molecular characterization of biologically derived reference materials before use in refined proteomic and related analytical applications.

Proteomes

13 November 2026

SDS-PAGE analysis of BSA preparations loaded at 5 and 1 µg. BSA preparations from: 1: Amersham/GE Health Care; 2: Merck-Sigma; 3: Sigma-Aldrich; 4: VWR. The analysis shows a clear predominance of the expected MW of 66.4 kDa and, for 5 µg BSA, faint bands at lower MW likely arising from proteolytic products of BSA in addition to higher MW of BSA oligomers, in agreement with previous findings [8]. Raw uncropped images of the stain-free and G-250 stained gels can be found in Supplementary Material, Figure S1.
  • Article
  • Open Access

Background: Persistence under refrigeration is an important feature of Listeria monocytogenes, yet the molecular basis underlying lineage-specific differences in adaptation to these conditions remains poorly understood. In this study, we investigated proteomic differences between two L. monocytogenes strains belonging to epidemiologically distinct clonal complexes (CCs), CC9 and CC1, which represent a food-associated, hypovirulent lineage and a hypervirulent, human-associated lineage, respectively. Methods: Cultures of the two L. monocytogenes strains were grown at 10 °C and analysed by label-free quantitative (LFQ) mass spectrometry. Identified proteins were subjected to in silico prediction of antigenic and virulence-associated properties, subcellular analysis, and functional annotation using KEGG pathways. Results: A total of 915 proteins were identified, of which 703 were predicted in silico to be antigenic and/or virulence-associated. Among these, 165 were detected only in the CC9 strain, 49 only in the CC1 strain, and 489 were shared by both strains. The shared protein complement included FlgE, Lmo0723, Dps, PrfA, and RecA, reflecting conserved functions related to motility, stress response, virulence regulation, and genome maintenance. Functional annotation assigned a larger number of proteins to metabolic and cellular pathways in the CC9 strain, largely reflecting the higher number of proteins detected only in this strain, whereas in the CC1 strain carbohydrate metabolism accounted for a larger proportion of the annotated proteins. Quantitative analysis further identified 19 proteins with increased abundance and 66 with decreased abundance in CC1 relative to CC9. Conclusions: These findings reveal distinct proteomic signatures in the CC1 and CC9 strains during growth at low temperature and suggest that their contrasting metabolic and stress-response profiles may be related to their different ecological and pathogenic characteristics. Validation in a larger panel of strains is required to establish whether these features are lineage-associated.

Proteomes

13 November 2026

Venn diagram showing the number and percentage of putatively antigenic and/or virulence-associated proteins detected in the food-associated, hypovirulent strain F (CC9) and the human-associated, hypervirulent strain H (CC1).

Highly Accessed Articles

News & Conferences

Latest Issues

Open for Submission

Journal Sections

XFacebookLinkedIn
Proteomes - ISSN 2227-7382